The present study sought to identify factors that influence pancreatic cancer progression via SP/NK-1R and the LOC389641, as well as its target gene, TNFRSF10A. Our results identified a possible target for treating pancreatic cancer. This evidence concerns the gene TACR1 and pancreatic neoplasm.